Q2 2017

Filed Oct 16, 2017 · 10-Q · 46 days after period end · 0001193805-17-003294

Q2 2017 · 10-Q

Revenue

$0.00

— vs Q2 2016

Net Income

-$43.00K

N/M vs Q2 2016

EPS Diluted

-$0.03

N/M vs Q2 2016

Operating Income-$22,000N/M

Operating Cash Flow

Same quarter

Metric	Q2 2017	Q2 2016	Q2 2015	Q2 2014
Revenue	$0.00	$0.00	$0.00	$0.00
Net Income	-$43.00K	-$32.00K	-$38.00K	-$29.00K
EPS Diluted	-$0.03	-$0.03	-$0.03	-$0.02

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Yubo International Biotech Ltd · CIK 895464 · Engraved from SEC EDGAR